The island will soon accept applications for medical cannabis cultivation licenses, but decriminalization will have to wait.
Cannabis Wire’s roundup and analysis of the top stories and trends in global cannabis business, policy, and research in 2019.
A decriminalization bill that also allows import, export, and business licenses is on the president’s desk.
After a marathon debate, lawmakers in the Caribbean’s largest economy pushed forward a bill that is likely to spark further reform in the region. Next: the Senate, possibly before the end of the year.
Regulators approved new rules for cannabis-based products, but patient advocates are disappointed and one lawmaker says the changes still don’t democratize access.
“It makes no sense to create wealth that will only increase economic inequality”—David Burt, premier of Bermuda
Laws are loosening and investors are interested, but who will reap the benefits?
Activists have had mixed reactions to the draft legislation and say that lawmakers should allow for a full adult use industry.
For decades, cannabis has been sold in coffee shops, but illegal to grow. A government experiment, approved by the Senate this week, aims to resolve that tension.
Nazma Muller is entering her fifth week of protest outside Trinidad and Tobago’s Parliament, as she pushes hard for cannabis law reform, and to include local players in an emerging legal industry.
Today, guidance was released for cannabis companies due to the "higher than usual crossover of financial interests" in the industry.
Sativex and Epidyolex were approved for reimbursement by the NHS for some conditions. But health officials say product costs are too high, and benefits too low, for patients with chronic pain.
Amid discord among international regulators, domestic lawmakers have drafted a host of bills to increase patient access to cannabis.
Legislators were working under a Supreme Court mandate to regulate in a way that promotes a new legal industry and curbs an old illegal one. Now they’re scrambling to regroup.
The government will soon have data to determine whether to approve medical cannabis use for pain relief.
The growing hemp industry lacks universal agreement on its THC threshold.